Eriksson, B I <br/><br/>
Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.  [electronic resource] 

 -  Thrombosis and haemostasis  Aug 1994 
 - 227-31 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Blood Loss, Surgical<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Hemorrhage--chemically induced<br/>Hip Prosthesis<br/>Hirudin Therapy<br/>Hirudins--administration & dosage<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Partial Thromboplastin Time<br/>Postoperative Complications--prevention & control<br/>Recombinant Proteins--administration & dosage<br/>Risk Factors<br/>Safety<br/>Thrombin--antagonists & inhibitors<br/>Thromboembolism--prevention & control